- 64 adults aged 45 to 65 finished 12 weeks of 10 grams creatine monohydrate or placebo, training or not
- Resting users added near 2.4 pounds of lean mass and lifted more on leg and bench press
- Paired with workouts and lighter eating, creatine lifted strength and fat share but not aerobic fitness
Your shelf may gain a small jar that keeps muscle closer through busy months. Researchers at Texas A&M University reported a 12-week randomized trial on August 11 of 10 grams of daily creatine monohydrate versus placebo in 64 healthy adults ages 45 to 65, with and without training and modest dieting. Takers who skipped workouts still added about 2.4 pounds of lean tissue and raised strength.
Volunteers first picked either a structured exercise and diet induced weight loss plan or a non-exercise track. Then each track was randomized to creatine or placebo. The active plan paired resistance training with aerobic training three times weekly, plus eating aimed at a small calorie shortfall.
In the non-exercise track, creatine raised leg press strength and bench press strength across 12 weeks. Inside the exercise and diet track, creatine users added nearly three pounds of lean tissue and lost fat mass. Meanwhile the exercise and diet track on placebo showed little shift in lean tissue.
Creatine with exercise also brought larger gains in leg and bench press strength and time to exhaustion. It gave no extra gain in aerobic capacity. People on creatine saw a larger fall in body fat percentage than with exercise and diet alone, which the researchers describe as the first such finding for creatine combined with exercise and diet induced weight loss.
For people in midlife, the frame is upkeep. Muscle and strength tend to fade with age and during weight loss, and holding lean tissue keeps daily motion easier to maintain. A powder that supports lean tissue without structured exercise feels simple, yet training still counted here toward greater strength gains.
There are caveats to keep in view. Since people chose the exercise path before randomization, contrasts between exercisers and non-exercisers stand on softer ground than creatine versus placebo contrasts. This was tested in a single 12 week study in 64 people who finished it. It leaves out long term outcomes, ages outside 45 to 65, and the cognitive and health markers in the title.
Dose and daily habits also call for care. The trial used 10 grams daily, and looked at no other dose level. Food intake, protein intake and daily activity in the non-exercise group may have influenced the results. A 2025 review of 685 clinical trials by the same group found no real gap in side effect rates for creatine and placebo. The current trial was guided by Dr. Richard Kreider, professor and director of the Exercise and Sport Nutrition Lab at Texas A&M, with funding from the WoodNext Foundation through the Texas A&M Foundation.
For now, treat this as a tight result rather than a habit. Creatine kept lean tissue and strength in this group, worked better with training and dieting, and left aerobic capacity unchanged.






